Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Lisinopril/HCTZ 20mg/12.5mg Tablet

Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.

Terminated Particulate / foreign matter RemedyRepack Inc. NDC 68180-0519-02 D-1030-2020
Class II · Moderate risk

Clear Eyes Redness Relief Hand Pocket Pal Tray Display

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1835-2019
Class II · Moderate risk

Clear eyes REDNESS RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1834-2019
Class II · Moderate risk

Clear Eyes Maximum Redness Relief Club Pack Display

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1831-2019
Class II · Moderate risk

Clear Eyes Redness Relief Club Pack Display

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1829-2019
Class II · Moderate risk

Clear Eyes Assorted Sidekick Floor Stand Display

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1828-2019
Class II · Moderate risk

Clear Eyes Assorted IRC Display

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1826-2019
Class II · Moderate risk

Clear eyes MAXIMUM REDNESS RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1825-2019
Class II · Moderate risk

Clear eyes MAXIMUM ITCHY EYE RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1824-2019
Class II · Moderate risk

Clear eyes REDNESS RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1823-2019
Class II · Moderate risk

Clear eyes REDNESS RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1822-2019

Recalls by year